PO:07:103 | Tocilizumab use in patients with rheumatoid arthritis and malignancy: a monocentric experience
Background. In 2024, the EULAR published a set of points to consider for initiating targeted therapy in rheumatoid arthritis (RA) patients with a history of malignancy, indicating TNF inhibitors are preferred in solid tumors, while rituximab is recommended for hematological malignancies. Although t...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
PAGEPress Publications
2025-11-01
|
| Reeks: | Reumatismo |
| Onderwerpen: | |
| Online toegang: | https://www.reumatismo.org/reuma/article/view/2021 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|